ArabFinance: October Pharma’s (OCPH) ordinary general meeting (OGM) has approved the distribution of EGP 24 million in cash dividends, equivalent to EGP 4 per share, for the year 2021, according to a filing to the Egyptian Exchange (EGX) on Sunday.

The OGM also approved the disbursement of 1-for-1 bonus shares.

It is worth noting that October Pharma recorded a net profit after tax of EGP 119.791 million in 2021, up from EGP 88.258 million in 2020.

October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.

The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.